0000000000595164

AUTHOR

Carlo Alberto Maggi

showing 2 related works from this author

Capsaicin desensitization in vivo is inhibited by ruthenium red.

1990

The effect of systemic administration of Ruthenium Red on the excitatory and desensitizing effect of capsaicin was investigated in rats. Ruthenium Red was injected s.c. 30 min before capsaicin was administered. The excitatory effect of capsaicin on corneal, perivascular and visceral afferents was not influenced by treatment with Ruthenium Red. However, determination of the neuropeptide content and evoked neuropeptide release in peripheral organs and dorsal spinal cord 48 h after treatment showed that Ruthenium Red attenuated the 'desensitizing' effect of capsaicin at peripheral, but not at central, endings of primary afferents. On the other hand, a capsaicin-elicited autonomic reflex mediat…

inorganic chemicalsRuthenium redCalcitonin Gene-Related PeptideInjections SubcutaneousCentral nervous systemUrinary BladderNeuropeptideBlood PressurePharmacologySubstance PSynaptic Transmissionchemistry.chemical_compoundIn vivootorhinolaryngologic diseasesAutonomic reflexmedicineAnimalsNeurons AfferentPharmacologyNerve EndingsNeuronsChemistryNeuropeptidesRats Inbred StrainsRuthenium RedRatsmedicine.anatomical_structureCapsaicinAnesthesiaExcitatory postsynaptic potentiallipids (amino acids peptides and proteins)NeuronCapsaicinEuropean journal of pharmacology
researchProduct

Dexketoprofen/tramadol: randomised double-blind trial and confirmation of empirical theory of combination analgesics in acute pain

2015

Background Combination analgesics are effective in acute pain, and a theoretical framework predicts efficacy for combinations. The combination of dexketoprofen and tramadol is untested, but predicted to be highly effective. Methods This was a randomised, double-blind, double-dummy, parallel-group, placebo-controlled, single-dose trial in patients with moderate or severe pain following third molar extraction. There were ten treatment arms, including dexketoprofen trometamol (12.5 mg and 25 mg) and tramadol hydrochloride (37.5 mg and 75 mg), given as four different fixed combinations and single components, with ibuprofen 400 mg as active control as well as a placebo control. The study objecti…

MaleKetoprofenWisdom toothEmpirical Researchlaw.inventionPostoperative painDolor postoperatoriRandomized controlled triallawDose rangeAntiinflammatory agentsTromethamineTramadolRandomised controlled trialAnalgesicsAnti-Inflammatory Agents Non-SteroidalAgents antiinflamatorisQueixal del senyGeneral MedicineMiddle AgedIbuprofenAcute PainAnalgesics OpioidKetoprofenAnesthesiaTramadol HydrochlorideDrug Therapy CombinationFemaleTramadolResearch Articlemedicine.drugAdultAdolescentAnalgesicClinical NeurologyPlaceboOdontologiaYoung AdultAnalgèsicsDouble-Blind MethodThird molarPosologymedicineDexketoprofenHumansPain ManagementCombination analgesicsbusiness.industryDexketoprofenPosologiaAnesthesiology and Pain MedicineDentistryNeurology (clinical)Analgesiabusiness
researchProduct